Darius Kharabi's Planned Sale of KALA BIO, Inc. Common Stock

Darius Kharabi, an officer of KALA BIO, Inc., has filed a Form 144 notice indicating his intention to sell 20,806 shares of the company's common stock. The shares were acquired as restricted stock on various dates between January 2024 and June 2025. The approximate sale date is set for October 22, 2025, with an aggregate market value of $17,283.54. The sale will be facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services. No securities were sold in the past three months. This filing is a routine disclosure of planned stock sales by an officer of the company.